RADPLAT: An alternative to surgery?

Oncologist

Volumn 11, Issue 5, 2006, Pages 469-480

  Alkureishi, Lee W T ^a   De Bree, Remco ^b   Ross, Gary L ^c  

^a CANNIESBURN PLASTIC SURGERY UNIT   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Head and neck cancer; Intra arterial chemotherapy; RADPLAT; Targeted chemoradiation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; SODIUM THIOSULFATE;

ADVANCED CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; DISEASE CONTROL; DISEASE SEVERITY; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; LYMPHADENOPATHY; ORGAN PRESERVATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 33646867646     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.11-5-469     Document Type: Review

References (81)

1. Marcial VA, Pajak TF. Radiation therapy alone or in combination with surgery in head and neck cancer. Cancer 1985;55:2259-2265.
2. Laramore GE, Scott CB, al-Sarraf M et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-713.
3. Hart AA, Mak-Kregar S, Hilgers FJ et al. The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands. Cancer 1995;75:2656-2662.
4. Robertson AG, Soutar DS, Paul J et al. Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours. Clin Oncol (R Coll Radiol) 1998;10:155-160.
5. Rooney M, Kish J, Jacobs J et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 1985;55:1123-1128.
6. Dreyfuss AI, Clark JR, Wright JE et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990;112:167-172.
7. Robbins KT, Hoffman RM. "Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. I. Histoculture experiments. Laryngoscope 1996;106:32-36.
8. Robbins KT, Storniolo AM, Hryniuk WM et al. "Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studies. Laryngoscope 1996;106:37-42.
9. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996;14:838-847.
10. Pignon JP, Bourhis J, Domenge C et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-955.
11. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-1952.
12. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-1690.
13. Zak M, Drobnik J. Effect of cis-dichlorodiamine platinum (II) on the post-irradiation lethality in mice after irradiation with X-rays. Strahlentherapie 1971;142:112-115.
14. Murthy AK, Taylor SG 4th, Showel J et al. Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1987;13:1807-1813.
15. Marcial VA, Pajak TF, Mohiuddin M et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer 1990;66:1861-1868.
16. Al-Sarraf M, Pajak TF, Marcial VA et al. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer 1987;59:259-265.
17. Taylor SG 4th, Murthy AK, Caldarelli DD et al. Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 1989;7:846-856.
18. Adelstein DJ, Sharan VM, Earle AS et al. Long-term results after chemoradiotherapy for locally confined squamous-cell head and neck cancer. Am J Clin Oncol 1990;13:440-447.
19. al-Sarraf M, Pajak TF, Cooper JS et al. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a Radiation Therapy Oncology Group study. J Clin Oncol 1990;8:1342-1351.
20. Malhotra H, Plosker GL. Cisplatin/epinephrine injectable gel. Drugs Aging 2001;18:787-793; discussion 794-785.
21. Andrews PA, Murphy MP, Howell SB. Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells. Eur J Cancer Clin Oncol 1989;25:619-625.
22. Andrews PA, Jones JA, Varki NM et al. Rapid emergence of acquired cisdiamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun 1990;2:93-100.
23. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-934.
24. Burian M, Formanek M, Regele H. Electroporation therapy in head and neck cancer. Acta Otolaryngol 2003;123:264-268.
25. Klopp CT, Smith DF, Alford TC. Palliation achieved in carcinoma of the head and neck with intra-arterial chemotherapy. Am J Surg 1961;102:830-834.
26. Sullivan RD. Continuous intra-arterial infusion chemotherapy of head and neck cancer. Trans Am Acad Ophthalmol Otolaryngol 1962;66:111-117.
27. Lee YY, Dimery IW, Van Tassel P et al. Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Arch Otolaryngol Head Neck Surg 1989;115:503-511.
28. Forastiere AA, Baker SR, Wheeler R et al. Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. J Clin Oncol 1987;5:1601-1606.
29. Cheung DK, Regan J, Savin M et al. A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers. Cancer 1988;61:903-908.
30. Mortimer JE, Taylor ME, Schulman S et al. Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (stage III and IV) head and neck cancers. J Clin Oncol 1988;6:969-975.
31. Frustaci S, Barzan L, Caruso G et al. Induction intra-arterial cisplatin and bleomycin in head and neck cancer. Head Neck 1991;13:291-297.
32. Eckman WW, Patlak CS, Fenstermacher JD. A critical evaluation of the principles governing the advantages of intra-arterial infusions. J Pharmacokinet Biopharm 1974;2:257-285.
33. Elferink F, van der Vijgh WJ, Klein I et al. Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin Chem 1986;32:641-645.
34. Kumar P, Robbins KT. Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the 'RADPLAT' protocol. Curr Oncol Rep 2001;3:59-65.
35. Howell SB, Taetle R. Effect of sodium thiosulfate on cis-dichlorodiammi neplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 1980;64:611-616.
36. Robbins KT, Kumar P, Wong FS et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687-693.
37. Robbins KT, Storniolo AM, Kerber C et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 1994;12:2113-2120.
38. Robbins KT, Vicario D, Seagren S et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994;168:419-422.
39. Robbins KT, Fontanesi J, Wong FS et al. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996;122:853-857.
40. Robbins KT, Kumar P, Regine WF et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997;38:263-271.
41. Adelstein DJ, Li Y, Adams GL et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-98.
42. Calais G, Bardet E, Sire C et al. Radiotherapy with concomitant weekly docetaxel for stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC phase II trial. Int J Radiat Oncol Biol Phys 2004;58:161-166.
43. Robbins KT, Wong FS, Kumar P et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:670-675.
44. Ahmed KA, Robbins KT, Wong F et al. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 2000;110:1789-1793.
45. Balm AJ, Rasch CR, Schornagel JH et al. High-dose superselective intraarterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 2004;26:485-493.
46. Robbins KT, Kumar P, Harris J et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol 2005;23:1447-1454.
47. Sullivan CA, Jaklitsch MT, Haddad R et al. Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancer. Laryngoscope 2004;114:1924-1931.
48. Gemmete JJ. Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. J Vasc Interv Radiol 2003;14:743-748.
49. Garden AS, Glisson BS, Ang KK et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 1999;17:2390-2395.
50. Rosen F, Vokes EE, Lad T et al. Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study. Invest New Drugs 1995;13:249-252.
51. Laurell G, Jungnelius U. High-dose cisplatin treatment: hearing loss and plasma concentrations. Laryngoscope 1990;100:724-734.
52. Madasu R, Ruckenstein MJ, Leake F et al. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1997;123:978-981.
53. Robbins KT, Doweck I, Samant S et al. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope 2004;114:411-417.
54. Doweck I, Denys D, Robbins KT. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope 2002;112:1742-1749.
55. Galmarini FC, Galmarini CM, Sarchi MI et al. Heterogeneous distribution of tumor blood supply affects the response to chemotherapy in patients with head and neck cancer. Microcirculation 2000;7:405-410.
56. Doweck I, Robbins KT, Vieira F. Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2001;127:1315-1318.
57. van den Broek GB, Rasch CR, Pameijer FA et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 2004;101:1809-1817.
58. Lazarus CL, Logemann JA, Pauloski BR et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996;106:1157-1166.
59. Staton J, Robbins KT, Newman L et al. Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg 2002;127:43-47.
60. Newman LA, Vieira F, Schwiezer V et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:589-592.
61. Johnston CA, Keane TJ, Prudo SM. Weight loss in patients receiving radical radiation therapy for head and neck cancer: a prospective study. JPEN J Parenter Enteral Nutr 1982;6:399-402.
62. Murry T, Madasu R, Martin A et al. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 1998;20:31-37.
63. Ackerstaff AH, Tan IB, Rasch CR et al. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002;128:1185-1190.
64. Wong RJ, Lin DT, Schoder H et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-4208.
65. Kubota K, Yokoyama J, Yamaguchi K et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590-595.
66. Agra IM, Carvalho AL, Pontes E et al. Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg 2003;129:1317-1321.
67. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 1995;121:162-165.
68. Ganly I, Patel S, Matsuo J et al. Postoperative complications of salvage total laryngectomy. Cancer 2005;103:2073-2081.
69. Leon X, Quer M, Orus C et al. Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy. Head Neck 2001;23:733-738.
70. Kutler DI, Patel SG, Shah JP. The role of neck dissection following definitive chemoradiation. Oncology (Williston Park) 2004;18:993-998; discussion 999, 1003-1004, 1007.
71. Robbins KT, Ferlito A, Suarez C et al. Is there a role for selective neck dissection after chemoradiation for head and neck cancer? J Am Coll Surg 2004;199:913-916.
72. McHam SA, Adelstein DJ, Rybicki LA et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
73. Samant S, Robbins KT, Kumar P et al. Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch Otolaryngol Head Neck Surg 2001;127:1451-1456.
74. Robbins KT, Samant S, Vieira F et al. Presurgical cytoreduction of oral cancer using intra-arterial cisplatin and limited concomitant radiation therapy (Neo-RADPLAT). Arch Otolaryngol Head Neck Surg 2004;130:28-32.
75. Madison ML 2nd, Sorenson JM, Samant S et al. The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation. J Neurooncol 2005;72:67-75.
76. Eisbruch A, Marsh LH, Martel MK et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys 1998;41:559-568.
77. Robbins KT. The evolving role of combined modality therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126:265-269.
78. Fountzilas G, Skarlos D, Kosmidis P et al. Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. A Hellenic Co-operative Oncology Group study. Acta Oncol 1994;33:825-830.
79. Huguenin P, Beer KT, Allal A et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004;22:4665-4673.
80. Jeremic B, Shibamoto Y, Milicic B et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000;18:1458-1464.
81. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-1944.